Mauritius lauded for its successful economic development in an exclusive report published by The Healthcare & Lifesciences Review
The Healthcare & Lifesciences Review in partnership with the Board of Investment Mauritius has published a comprehensive report on the Mauritian Healthcare and Life Sciences Industry.
The report features exclusive interviews of Her Excellency Dr. Ameenah Gurib-Fakim, President of Mauritius, Mr. Ken Poonoosamy, Managing Director of the Board of Investment, Dr Arjoon Suddhoo, Executive Director of Mauritius Research Council, Mr. Salim Ismail, Chairman & CEO, GROUPE SOCOTA and Heads of multinational and local companies, amongst others.
This report provides an invaluable insight into the opinions, challenges and opportunities within the Mauritian healthcare market. Areas of coverage include Pharmaceuticals, Biotech, Medical Devices.
Contributions from key organisations such as CIDP, GML, IBL, Insight Research, Mauritius Commercial Bank, Board of Investment, Mauritius Research Council, Mérieux NutriSciences, NATEC Medical, Omnicane, Pharmacie Nouvelle Limited, QuantiLAB, Socota Phoenicia and the University of Mauritius are featured.
The Economic Vision 2030 highlights the ambition of the Government to transform the country into a high-income economy. The Healthcare and Life Science sector will play a key role in this transformation.